Free POST Trial Brief - District Court of Delaware - Delaware


File Size: 158.9 kB
Pages: 4
Date: December 31, 1969
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 705 Words, 4,277 Characters
Page Size: 616 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/7531/133-6.pdf

Download POST Trial Brief - District Court of Delaware ( 158.9 kB)


Preview POST Trial Brief - District Court of Delaware
Case 1:04-cv-00179-SLR Document 133-6 Filed 10/06/2006 Page 1 014
EXHIBIT B

Case 1:04-cv-00179-SLR Document 133-6 Filed 10/06/2006 Page 2 of 4
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
BAYER AG, BAYER HEALTHCARE AG, )
and BAYER PHARMACEUTICALS )
CORPORATION )
Plaintiffs and I
Counterclaim Defendants, )
v. i Civil Action N0. 04-179 (SLR)
DR. REDDY’S LABORATORIES, LTD. and I
DR. REDDY’S LABORATORIES, INC., )
Defendants g
and Counterclaimants. )

|PROPOSED| FINAL JUDGMENT ORDER
The Court having conducted a trial in the above-referenced matter and having
reviewed the parties’ post-trial briefs and heard oral argument, hereby enters judgment in the
above-referenced matter as follows:
1. The rnoxifloxacin hydrochloride tablet product of Dr. Reddy’s
Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc.’s (collectively, "Reddy") Abbreviated New
Drug Application ("ANDA") No. 76-938 infringes each of claims 1, 2, 8, and 9 of U.S. Patent
No. 4,990,517 ("the ’517 patent") and each of claims 1, 2, 3, and 4 of U.S. Patent 5,607,942
("the ’942 patent"). The bulk active pharmaceutical ingredient of Reddy’s DMF 16999 infringes
each of claims 1 and 2 of the ’5l7 patent and each of claims 1, 2, 3 and 4 of the ’942 patent. The
use of the rnoxifloxacin hydrochloride tablet product of Reddy’s ANDA No. 76-938 when used
in accord with any label submitted now or in the future in Reddy’s ANDA 76-938 infringes each
of claims 1, 2, 8, 9, and 11 ofthe ’517 patent and each of claims 1, 2, 3, 4, 5, and 7 ofthe ’942
patent.
Rm-3067265-1

Case 1:04-cv-00179-SLR Document 133-6 Filed 10/06/2006 Page 3 of 4
2. The claims of the ’5 17 patent and the ’942 patent are not invalid.
3. The ’5l7 patent and the ’942 patent are not unenforceable.
4. Pursuant to 35 U.S.C. § 27l(e)(4)(A), the effective date of any Food and
Drug Administration approval of Reddy’s ANDA No. 76-938 shall be a date not earlier than
March 4, 2014, the later of the expiration dates of the ’5 17 patent and the ’942 patent.
5. Pursuant to 35 U.S.C. § 27l(e)(4)(B), Reddy, their officers, agents,
attorneys and employees, and those acting in privity or concert with any of them, are hereby
enjoined from engaging in the commercial manufacture, use, offer to sell, or sale with the United
States, or importation into the United States, of moxifloxacin hydrochloride or any drug product
containing moxiiloxacin hydrochloride or any compound or drug product within the scope of
claim l or 2 of the ’942 patent on or before March 4, 2014, the later of the expiration dates of the
’5 17 patent and the ’942 patent.
6. Judgment is hereby entered in favor of Plaintiffs and against Defendants
on Plaintiffs’ claims of infringement of the ’5 l 7 patent and the ’942 patent.
7. Judgment is hereby entered in favor of Plaintiffs and against Defendants
on Defendants’ counterclaims that the claims of the ’5l7 patent and the ’942 patent are invalid
and unenforceable.
8. Plaintiffs are hereby awarded their costs in this action.
SO ORDERED this _____~ day of __ ______, 200__
”`”`*"—”`"`”*
Chief United States District Judge
RLr1-s06726s-1

Case 1:04-cv-00179-SLR Document 133-6 Filed 10/06/2006 Page 4 of 4
CERTIFICATE OF SERVICE
I hereby certify that on October 6, 2006, I caused to be served by hand delivery
the foregoing document and electronically filed the same with the Clerk of Court using
CM/ECF which will send notification of such ti1ing(s) to the following:
Richard L. Horwitz
David E. Moore
Potter Anderson & Corroon LLP
Hercules Plaza, 6m Floor
1313 North Market Street
Wilmington, DE 19801
I hereby certify that on October 6, 2006, I sent by Federal Express the foregoing
document to the following non-registered participants:
Louis H. Weinstein
Frank D. Rodriguez
David J. Novak
A. Michael Covino
Budd Lanier, PC
150 John F. Kennedy Parkway
Short Hills, NJ 07078-2703
jik
Anne Shea Gaza (#4093)
GAZA@r1f.com
RLFI-3052040-1

Case 1:04-cv-00179-SLR

Document 133-6

Filed 10/06/2006

Page 1 of 4

Case 1:04-cv-00179-SLR

Document 133-6

Filed 10/06/2006

Page 2 of 4

Case 1:04-cv-00179-SLR

Document 133-6

Filed 10/06/2006

Page 3 of 4

Case 1:04-cv-00179-SLR

Document 133-6

Filed 10/06/2006

Page 4 of 4